Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Shreefal Mehta
DIRECTOR, PULMOKINE INC.
Prescient Diagnostics: Implications for Product Development and Reimbursement
Placeholder Photo
Innes Meldrum
PRESIDENT AND CEO, RESET PHARMA
Reset Pharma
morristown, New York, United States
Michelle Mellion, MD
SENIOR VICE PRESIDENT, HEAD OF CLINICAL DEVELOPMENT, PEPGEN
Gene Therapy: Let’s Talk about Safety, Baby
Cambridge, Massachusetts, United States
Sandra Melvin, DrPPH, MPH
CEO AND FOUNDER, INSTITUTE FOR THE ADVANCEMENT OF MINORITY HEALTH
Preparedness and Treatment Equity Coalition Informing System Reform to Improve Health Outcomes and Health Equity
Sandeep Menon, PhD
CHIEF DEVELOPMENT OFFICER, HEAD OF DEVELOPMENT AND SAFETY, ALNYLAM
Is Your Billion-Dollar Oncology AI Cutting-Edge Technology or is it Artificial Ignorance?
Boston, Massachusetts, United States
Kate Mevis
EXECUTIVE DIRECTOR, MERCK
Spotlight on Innovation: Conquering RSV Across the Life Course
Romain Micol
PRESIDENT AND CO-FOUNDER CEO, COMBINED THERAPEUTICS
Combined Therapeutics
Boston, Massachusetts, United States
Andrea Miele, PhD
ASSISTANT PROFESSOR OF PEDIATRICS, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE
Precompetitive Collaborations in Rare Disease Research
Debra Miller
CHIEF EXECUTIVE OFFICER AND FOUNDER, CUREDUCHENNE
Realizing the Promise of Gene Therapy and Gene Editing: Current Challenges, Opportunities and Trends
Alexis Miller
U.S. LEAD, GLOBAL REGULATORY POLICY, MERCK
Combating Misinformation with Authoritative Medical Product Information
FDA Sponsor Interaction: Best Practices and New PDUFA Formal Meetings
Rockville, Maryland, United States